Month Year
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
Month Year
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
-
Feb 3, 2003Insmed Incorporated Reports Year-End and Fourth Quarter Financial Results
-
Jan 29, 2003Insmed Reports Positive Effects of SomatoKine -rhIGF-I/rhIGFBP-3- In Adolescent Subjects With Type 1 Diabetes
-
Jan 28, 2003Insmed Incorporated to Webcast Fourth Quarter Earnings Conference Call; Tuesday, February 4, at 8:00 a.m. ET - 7:00 a.m. CT
-
Jan 27, 2003Insmed Incorporated Appeals Delisting Notification From Nasdaq
-
Jan 7, 2003Insmed Incorporated Announces Positive Preclinical Oncology Data With rhIGFBP-3
-
Nov 4, 2002Insmed Presents IGFBP-3 Anti-Cancer Data at the International Symposium on the Functional Role of IGFBP's
-
Oct 31, 2002Insmed Incorporated To Webcast Third Quarter Earnings Conference Call; Thursday, October 31, 2002, at 8:30 a.m. ET -7:30 a.m. CT
-
Oct 30, 2002Insmed Incorporated Reports Third Quarter Results
-
Oct 7, 2002Insmed Acquires IGF-1 Regulatory Files for Growth Hormone Insensitivity Syndrome From Pharmacia; Extensive Regulatory Files Expected to Expedite Commercialization of SomatoKine